Jay Kellison is a seasoned healthcare executive and board advisor with over 40 years of experience leading behavioral health and addiction treatment organizations across 21 U.S. states. With expertise in turnaround management, strategic growth, and financial optimization, he has successfully overseen hospital systems, residential treatment centers, and outpatient psychiatric programs in both for-profit and non-profit sectors. Throughout his career, Jay has held executive leadership roles at Acadia Healthcare, HCA Healthcare, Universal Health Services, Rogers Behavioral Health, and Latticework Capital Management, where he has driven operational excellence, expanded service lines, and optimized financial performance. A dedicated mentor and industry leader, Jay is passionate about developing executive talent, advising investors, and helping organizations navigate complex healthcare landscapes. His guiding principle, “treat others as you want to be treated,” reflects his commitment to ethical leadership, collaboration, and sustainable growth in the behavioral healthcare sector.

The healthcare investment landscape is undergoing a revolutionary transformation, addressing the binary risk and inefficiency that have long plagued therapeutic R&D. Traditional drug development processes are slow, costly, and fraught with failure, but advances in AI are now enabling faster, more accurate drug discovery and validation. Leveraging this potential, a novel funding model has emerged, combining insurance underwriting by Lloyd’s of London and non-dilutive lending, supported by AI-driven validation technology from GATC Health. This approach reduces risk for all stakeholders, accelerates funding timelines, and maximizes the chances of success for biotech startups. With nearly 100 startups already in the pipeline, this innovative funding vehicle promises to expedite therapeutic breakthroughs, benefiting investors, companies, and most importantly, patients in need.